HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Results for CTL/CD8+ T-Cell Epitope Variants

Filter results by Mutation Type:

LGQLQPSLQTGSEELRSLYN Gag(61-80) human epitope
  QLQPSLQTGSEELR Gag(63-76) human epitope
  QLQPSLQTGSEELRSLY Gag(63-79) human epitope
        QTGSEELRSLYNTVATLYCVHQRIE Gag(69-93) A2 human epitope
         TGTEELRSLYNTVATLY Gag(70-86) C*14 human epitope
         TGSEELRSLYNTVATLY Gag(70-86) human epitope
         TGSEELRSLYNTVATLY Gag(70-86) human epitope
          GSEELRSLY Gag(71-79) A*01 human epitope
          GSEELkSLY Gag(71-79) escape documented in this paper; observed variant
          GSaELRSLY Gag(71-79) escape documented in this paper; observed variant
          GSEELRSLf Gag(71-79) escape documented in this paper; observed variant
          GSEELRSLY Gag(71-79) A*01 human epitope
          GSEELRSLf Gag(71-79) escape documented in this paper
          GSEELRSLc Gag(71-79) inferred escape
          GSEELKSLY Gag(71-79) A*01 human epitope
          GSEELrSLY Gag(71-79) susceptible form
          GSEELRSLY Gag(71-79) A*01 human epitope
          GSEELkSLY Gag(71-79)
          GSEELRSLf Gag(71-79)
          GSEELRSLY Gag(71-79) A*01 human epitope
          GSEELRSLY Gag(71-79) A*01 human epitope
          GSEELRSLY Gag(71-79) A*01 epitope
          GSEELRSLY Gag(71-79) A*01 human epitope
          GTEELRSLY Gag(71-79) A*01:01 human epitope
          GTEELRSLf Gag(71-79) diminished HLA binding or increased off-rate; escape documented in this paper
          GSEELRSLY Gag(71-79) A*01:01 human epitope
          GSEEikSLY Gag(71-79) diminished HLA binding or increased off-rate; escape documented in this paper
          GSEELRSLY Gag(71-79) A*01:01 human epitope
          GTEELRSLY Gag(71-79) A*01:01 human epitope
          GSEELRSLY Gag(71-79) A*01:01, B*57 human epitope
          GSEELRSLY Gag(71-79) A1 human epitope
          GSEELRSLY Gag(71-79) A1 human epitope
          GSEELRSLY Gag(71-79) A1 epitope
          GSEELRSLY Gag(71-79) A1 human epitope
          GSEELRSLY Gag(71-79) A1 human epitope
          GSEELRSLY Gag(71-79) A1 human epitope
          GSEELRSLY Gag(71-79) A1 human epitope
          GtEgikSLh Gag(71-79) observed variant
          GSEELRSLY Gag(71-79) A1 human epitope
          GSEELRSLY Gag(71-79) A1 human epitope
          GSEELRSLY Gag(71-79) B*07 human epitope
          GSEELRSLY Gag(71-79) C*14 human epitope
          GTEELRSLY Gag(71-79) human epitope
          GTEELKSLY Gag(71-79) human epitope
          GSEELRSLY Gag(71-79) human epitope
          GSEELRSLYNTVATL Gag(71-85) human epitope
          GSEELRSLYNTVATL Gag(71-85) human epitope
          GSEELRSLYNTVATLYCVHQ Gag(71-90) human epitope
          GSEELRSLYNTVATLYCVHQ Gag(71-90) human epitope
            EELRSLYNT Gag(73-81) human epitope
            EELRSLYNTV Gag(73-82) B*40:06 human epitope
            EELRSLYNTVATLYC Gag(73-87) A2 human epitope
            EELRSLYNTVATLYCVHQ Gag(73-90) human epitope
            EELKSLFNTIAVLWCVHQ Gag(73-90) human epitope
            EELKSLFNTvAVLWCVHk Gag(73-90) observed variant
            EELKSLFNTvAVLWCVHQ Gag(73-90) observed variant
            EELKSLFNTvAVLcCVHQ Gag(73-90) observed variant
            EELKpLFNTvAVLcCVHQ Gag(73-90) observed variant
             ELRSLYNTV Gag(74-82) A*24 human epitope
             ELRSLYNTV Gag(74-82) B*08 human epitope
             ELRSLYNTV Gag(74-82) B*08 human epitope
             ELRSLYNTi Gag(74-82) observed variant
             ELRSLfNTi Gag(74-82) observed variant
             ELRSLcNTi Gag(74-82) observed variant
             ELRSLYNai Gag(74-82) observed variant
             ELRSLYNTV Gag(74-82) B*08 epitope
             ELKSLYNTV Gag(74-82) B*08 human epitope
             ELrSLYNTV Gag(74-82) susceptible form
             ELRSLYNTV Gag(74-82) B*08 human epitope
             ELRSLYNTV Gag(74-82) B*08 human epitope
             ELRSLYNTV Gag(74-82) B*08:01 human epitope
             ELRSLYNTV Gag(74-82) B*08:01 human epitope
             ELRSLYNTV Gag(74-82) B*08:01 human epitope
             ELRSLYNTV Gag(74-82) B*40 human epitope
             ELRSLYNTV Gag(74-82) B*52 human epitope
             ELRSLYNTV Gag(74-82) B8 human epitope
             ELKSLFNTI Gag(74-82) B8 human epitope
             ELRSLYNTV Gag(74-82) B8 human epitope
             ELRSLYNTV Gag(74-82) B8 human epitope
             ELRSLYNTV Gag(74-82) B8 human epitope
             ELkSLYNTV Gag(74-82) observed variant
             ELkSLYNTi Gag(74-82) inferred escape
             ELkSLfNTV Gag(74-82) observed variant
             ELKSLyNTV Gag(74-82) reversion
             ELRSLYNTV Gag(74-82) B8 human epitope
             ELRSLYNTV Gag(74-82) B8 epitope
             ELRSLYNTV Gag(74-82) B8 human epitope
             gikSLhNTV Gag(74-82) observed variant
             ELRSLYNTV Gag(74-82) B8 human epitope
             ELRSLYNTV Gag(74-82) B8 human epitope
             ELRSLYNTV Gag(74-82) C*06 human epitope
             ELRSLYNTV Gag(74-82) human epitope
             ELRSLYNTV Gag(74-82) human epitope
             ELRSLYNTVA Gag(74-83) A2 human epitope
             ELKSLYNTVATLYCV Gag(74-88) human epitope
             ELrSLfNTVATLYCV Gag(74-88) subtype-specific susceptible form
             eELrSLYNTVATLYCV Gag(74-88) subtype-specific susceptible form
             ELrSLYNTVATLYCV Gag(74-88) subtype-specific susceptible form
             LKSLfNTVATLYCVH Gag(74-88) subtype-specific susceptible form
               KSLYNTVCV Gag(76-84) H-2Db mouse epitope
               RSLYNTVATLY Gag(76-86) A*02 human epitope
               RSLYNTVATLY Gag(76-86) A*02:01, A*30:02 human epitope
               RSLYNTiATLY Gag(76-86) diminished response; escape documented in this paper
               RSLYNTVAvLY Gag(76-86) diminished response; escape documented in this paper
               RSLYNTiAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
               RSLfNTiATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
               RSLfNTVATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
               RSLfNTVAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
               RSLfNTiAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
               kSLYNTVATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response
               kSLYNTVAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
               kSLYNTiATLY Gag(76-86) diminished response; escape documented in this paper
               kSLYNTiAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
               kSLfNTVATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
               kSLfNTiATLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
               kSLfNTVAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
               kSLfNTiAvLY Gag(76-86) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper
               RSLYNTVATLY Gag(76-86) A*29 human epitope
               RSLYNTVATLY Gag(76-86) A*30 human epitope
               RSLfNTVATLY Gag(76-86) observed variant
               kSLYNTVATLY Gag(76-86) literature escape
               RSLYNTVAvLY Gag(76-86) observed variant
               RSLYNTiATLY Gag(76-86) observed variant
               RSLYNTVvTLY Gag(76-86) observed variant
               RSLYNTVATLY Gag(76-86) A*30 human epitope
               RSLYNTVAVLY Gag(76-86) A30 human epitope
               RSLYNTVATLY Gag(76-86) A30 epitope
               RSLYNTVATLY Gag(76-86) A30 human epitope
               RSLYNTVATLY Gag(76-86) A30 human epitope
               RSLYNTVATLY Gag(76-86) A30 human epitope
               RSLYNTVATLY Gag(76-86) A30 human epitope
               RSLYNTVATLY Gag(76-86) A30 human epitope
               RSLYNTATLY Gag(76-86) A30 human epitope
               RSLYNTVATLY Gag(76-86) A30 human epitope
               RSLYNTVATLY Gag(76-86) A*30:02 human epitope
               kSLYNTVATLY Gag(76-86) inferred escape
               kSLYNTVAvLY Gag(76-86) inferred escape
               RSLYNTVATLY Gag(76-86) A*30:02 human epitope
               RSLYNTVATLY Gag(76-86) A*30:02 human epitope
               RLSYNTVATLY Gag(76-86) A*30:02 human epitope
               RSLYNTVATLY Gag(76-86) A*30:02 human epitope
               RSLYNTVATLY Gag(76-86) A*30:02 human epitope
               RSLYNTVATLY Gag(76-86) A*30:02 human epitope
               RSLYNTVATLY Gag(76-86) A*30:02 human epitope
               RSLYNTVATLY Gag(76-86) A*30:02 human, macaque epitope
               RSLYNTVATLc Gag(76-86) escape documented in this paper
               kSLfNTVATLc Gag(76-86) escape documented in this paper
               RSLfNTiATLf Gag(76-86) escape documented in this paper
               RSLYNTVATLY Gag(76-86) A*30:02 human epitope
               RSLYNTVATLY Gag(76-86) A*30:02 human epitope
               RSLYNTVATLY Gag(76-86) B57, B58, B63 human epitope
               RSLYNTVATLY Gag(76-86) B*58 human epitope
               RSLYNTVATLY Gag(76-86) B*63 human epitope
               RSLYNTVATLY Gag(76-86) C*03 human epitope
               RSLYNTVATLY Gag(76-86) human epitope
               RSLFNTVATLY Gag(76-86) human epitope
               RSLyNTVATLY Gag(76-86) observed variant
               KSLYNTVVTLWCVHQ Gag(76-90) human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVAvL Gag(77-85) subtype-specific susceptible form
                SLfNTVATL Gag(77-85) subtype-specific susceptible form
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTiATL Gag(77-85) susceptible form
                SLfNTVATL Gag(77-85) susceptible form
                SLfNTVAvL Gag(77-85) susceptible form
                SLfNTiAvL Gag(77-85) susceptible form
                SLhNTVATL Gag(77-85) escape documented in this paper; TCR related mutation
                SLYaaaAaL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTiATL Gag(77-85) susceptible form
                SLfNTiATL Gag(77-85) diminished response; escape documented in this paper
                SLYNaiATL Gag(77-85) inferred escape
                SLcNTiATL Gag(77-85) inferred escape
                SLFNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLFNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLfNTVAvL Gag(77-85) diminished response
                SLvNTiATL Gag(77-85) diminished response
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 epitope
                SLFNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVAvL Gag(77-85) HLA association; processing
                SLfNTVATL Gag(77-85) HLA association; processing
                SLYNTiATL Gag(77-85) HLA association; processing
                SLYNTiAvL Gag(77-85) HLA association; processing
                SLfNTiATL Gag(77-85) HLA association; processing
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTIATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLfNTiAvL Gag(77-85) escape documented in this paper
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02 human epitope
                SLYNTVATL Gag(77-85) A*02:01 mouse epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLfNTVATL Gag(77-85) escape documented in this paper; susceptible form
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLfNaiAvL Gag(77-85) subtype-specific non-susceptible form
                SLfNTVATL Gag(77-85) subtype-specific non-susceptible form
                SLYNTiATL Gag(77-85) subtype-specific susceptible form
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLhNaVAvL Gag(77-85) escape documented in this paper
                SLfNTVATL Gag(77-85) escape documented in this paper
                SLYNTiAvL Gag(77-85) susceptible form
                SLhNTVATL Gag(77-85) escape documented in this paper
                SLlNTVATL Gag(77-85) observed variant
                SLYNTVAvL Gag(77-85) observed variant
                SLYNTiATL Gag(77-85) observed variant
                SLsNTiATL Gag(77-85) observed variant
                SLfNTVAvL Gag(77-85) observed variant
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLFNTVATL Gag(77-85) A*02:01 human epitope
                SLyNTVATL Gag(77-85) subtype-specific non-susceptible form
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 humanized mouse epitope
                SLYNTVATL Gag(77-85) A*02:01 mouse epitope
                SLYNTVATL Gag(77-85) A*02:01 mouse epitope
                SLYNTVATL Gag(77-85) A*02:01 epitope
                SLfNTVATL Gag(77-85) susceptible form
                SLYNTiATL Gag(77-85) susceptible form
                SLYNTVAvL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 mouse epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLfNTVATL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper
                SLfNTVAvL Gag(77-85) escape documented in this paper; TCR related mutation
                SLYNTVvTL Gag(77-85) inferred escape
                SLfNTiATL Gag(77-85) inferred escape
                SLYNTiAvL Gag(77-85) escape documented in this paper; TCR related mutation
                SLhNTVAvL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper
                SLYNTVAvL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTiATL Gag(77-85) escape documented in this paper; processing; susceptible form
                SvYNTVATL Gag(77-85) escape documented in this paper; processing; susceptible form
                SLYNlVATL Gag(77-85) escape documented in this paper; processing; susceptible form
                SLfNTVAvL Gag(77-85) escape documented in this paper; processing; susceptible form
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTIATL Gag(77-85) A*02:01 human epitope
                SLYNTIAvL Gag(77-85) susceptible form
                SLYNTvATL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) A*02:01 human, transgenic mouse epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 transgenic mouse epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLfNTiATL Gag(77-85) subtype-specific non-susceptible form; subtype-specific susceptible form
                SLYNTVATL Gag(77-85) A*02:01 human, transgenic mouse epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLFNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVAAL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVAvL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper; literature escape; susceptible form
                {k}SLfNTVAvL Gag(77-85) literature escape
                {k}SLfNTiAvL Gag(77-85) literature escape
                {k}SLYNTVATL Gag(77-85) literature escape
                SLfNTVATL Gag(77-85) escape documented in this paper; literature escape; susceptible form
                {k}SLfNTiATL Gag(77-85) literature escape
                {k}SLfNTVATL Gag(77-85) literature escape
                SLYNTiATL Gag(77-85) diminished HLA binding or increased off-rate; diminished response; escape documented in this paper; literature escape; susceptible form
                SLYNTiAvL Gag(77-85) diminished HLA binding or increased off-rate; escape documented in this paper; literature escape; susceptible form
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTiAvL Gag(77-85) literature escape
                SLfNTVATL Gag(77-85) literature escape
                SLYNTiATL Gag(77-85) literature escape
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLfNTVATL Gag(77-85) susceptible form
                SLYNTiATL Gag(77-85) susceptible form
                SLfNTiATL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVVTL Gag(77-85) A*02:01 human epitope
                SLYNTVaTL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLFNTVATL Gag(77-85) A*02:01 human epitope
                SLFNTVAAL Gag(77-85) diminished response
                SLFNTVATP Gag(77-85) diminished response
                SLFSTVATL Gag(77-85) observed variant
                SLFNTIATL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLfNTVATL Gag(77-85) subtype-specific susceptible form
                SLYNTiaTL Gag(77-85) subtype-specific susceptible form
                SLYNIiAvL Gag(77-85) subtype-specific susceptible form
                SLYNTVAvL Gag(77-85) subtype-specific susceptible form
                SLfNTiATL Gag(77-85) subtype-specific susceptible form
                SLfNTiAvL Gag(77-85) subtype-specific susceptible form
                SLfNTVAvL Gag(77-85) subtype-specific susceptible form
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 humanized mouse epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                SLfNTVATL Gag(77-85) diminished HLA binding or increased off-rate
                SLYNTVAvL Gag(77-85) diminished HLA binding or increased off-rate
                SLYNTiATL Gag(77-85) diminished HLA binding or increased off-rate
                SLfNTiAvL Gag(77-85) diminished HLA binding or increased off-rate; literature escape
                SLYNTVATL Gag(77-85) A*02:01 human epitope
                {l}SLYNTVAvL Gag(77-85) observed variant
                {l}SLYNTVATL Gag(77-85) susceptible form
                {m}SLYNTVATL Gag(77-85) observed variant
                SLYNaVAvL Gag(77-85) non-susceptible form
                {m}SLYNTVAvL Gag(77-85) observed variant
                {i}SLYNTVATL Gag(77-85) observed variant
                aLYNTVAvL Gag(77-85) observed variant
                aLfNTVATL Gag(77-85) observed variant
                SLYNiVATL Gag(77-85) observed variant
                {q}SLYNTVAvL Gag(77-85) observed variant
                {q}SLYNTVATL Gag(77-85) observed variant
                {v}SLYNTVATL Gag(77-85) observed variant
                SLYNcVATL Gag(77-85) observed variant
                {t}SLYNTVATL Gag(77-85) observed variant
                SLYNTiAsL Gag(77-85) observed variant
                SLYNsVAvL Gag(77-85) observed variant
                SLYNciATL Gag(77-85) observed variant
                aLYNTVATL Gag(77-85) observed variant
                SLYNTVAvL Gag(77-85) observed variant
                SLYNlVATL Gag(77-85) observed variant
                {t}SLYNTVAvL Gag(77-85) observed variant
                {v}SLYNTVAvL Gag(77-85) observed variant
                SLYNTiAvL Gag(77-85) observed variant
                {l}SLYNlVATL Gag(77-85) observed variant
                {n}SLYNTVAvL Gag(77-85) observed variant
                {f}SLYNTVATL Gag(77-85) observed variant
                SLYNTiATL Gag(77-85) observed variant
                SLYNTVAcL Gag(77-85) non-susceptible form
                {l}SLYNTVAcL Gag(77-85) observed variant
                {l}SLYNTVATL{w} Gag(77-85) observed variant
                {c}SLYNTVATL Gag(77-85) observed variant
                {k}SLYNTVATL Gag(77-85) observed variant
                SLYNcVAcL Gag(77-85) non-susceptible form
                SLYNTcAvL Gag(77-85) observed variant
                SLYNTVAsL Gag(77-85) observed variant
                SLfNTVATL Gag(77-85) observed variant
                SLYNlVAvL Gag(77-85) observed variant
                SLYNTVAaL Gag(77-85) observed variant
                {m}SLYNlVATL Gag(77-85) observed variant
                {v}SLYNlVATL Gag(77-85) observed variant
                {h}SLYNTVATL Gag(77-85) observed variant
                {a}SLYNTVATL Gag(77-85) observed variant
                SLYNTVATL{c} Gag(77-85) observed variant
                SLYNTVATL{f} Gag(77-85) observed variant
                {v}SLYNTVATL{w} Gag(77-85) observed variant
                {m}SLYNTVATL{w} Gag(77-85) observed variant
                {w}SLYNTVATL Gag(77-85) observed variant
                {s}SLYNTVATL Gag(77-85) observed variant
                {n}SLYNTVATL Gag(77-85) observed variant
                {a}aLYNTVATL Gag(77-85) observed variant
                {l}aLYNTVATL Gag(77-85) observed variant
                {l}SLYsTVATL Gag(77-85) observed variant
                {c}SLYNTVAvL Gag(77-85) observed variant
                {s}SLYNTVAvL Gag(77-85) observed variant
                {v}SLYNTVAsL Gag(77-85) observed variant
                {l}SLYNTVAaL Gag(77-85) observed variant
                {v}SLYNTVAaL Gag(77-85) observed variant
                SLYNTVAvL{w} Gag(77-85) observed variant
                SLYNTVAvL{s} Gag(77-85) observed variant
                SLYNTVAvL{r} Gag(77-85) observed variant
                SLYNTVATL{w} Gag(77-85) observed variant
                SLYNTVATm Gag(77-85) observed variant
                aLYNTVAaL Gag(77-85) observed variant
                aLYNTVAsL Gag(77-85) observed variant
                SLYNaVATL Gag(77-85) observed variant
                SLYNsVATL Gag(77-85) observed variant
                SLYNvVATL Gag(77-85) observed variant
                SLYNrVATL Gag(77-85) observed variant
                SLYNlVAsL Gag(77-85) observed variant
                SLYNvVAsL Gag(77-85) observed variant
                gLYNTVAvL Gag(77-85) observed variant
                cLYNTVAvL Gag(77-85) observed variant
                gLYNTVATL Gag(77-85) observed variant
                mLYNTVATL Gag(77-85) observed variant
                SLYmTVATL Gag(77-85) observed variant
                SLYrTVATL Gag(77-85) observed variant
                SLYgTVAvL Gag(77-85) observed variant
                SLYsTVAvL Gag(77-85) observed variant
                SLYcTVAvL Gag(77-85) observed variant
                SLYgTVAsL Gag(77-85) observed variant
                SLYgTVgTL Gag(77-85) observed variant
                SLYNTVgTL Gag(77-85) observed variant
                SLYNTVsTL Gag(77-85) observed variant
                SLYNTcATL Gag(77-85) observed variant
                SiYNTVATL Gag(77-85) observed variant
                StYNTVATL Gag(77-85) observed variant
                ScYNTVATL Gag(77-85) observed variant
                SvYNTVATL Gag(77-85) observed variant
                avYNTVATL Gag(77-85) observed variant
                vLYNTVATL Gag(77-85) observed variant
                tLYNTVATL Gag(77-85) observed variant
                rLYNTVATL Gag(77-85) observed variant
                wLYNTVATL Gag(77-85) observed variant
                qLYNTVATL Gag(77-85) observed variant
                SLYyTVATL Gag(77-85) observed variant
                SLYvTVATL Gag(77-85) observed variant
                SLYfTVATL Gag(77-85) observed variant
                SLYsTVATL Gag(77-85) observed variant
                SLYlTVATL Gag(77-85) observed variant
                SLYaTVATL Gag(77-85) observed variant
                SLYtTVATL Gag(77-85) observed variant
                SLYgaVATL Gag(77-85) observed variant
                SLYyTVAvL Gag(77-85) observed variant
                SLYslVATL Gag(77-85) observed variant
                SLYNvlATL Gag(77-85) observed variant
                SLYNTtATL Gag(77-85) observed variant
                SLYNTlATL Gag(77-85) observed variant
                SLYNTVgvL Gag(77-85) observed variant
                SLYNTVAiL Gag(77-85) observed variant
                SLrNTVATL Gag(77-85) observed variant
                SLvNTVATL Gag(77-85) observed variant
                SLwNTVATL Gag(77-85) observed variant
                SLYNTVATv Gag(77-85) observed variant
                SLYNTVATi Gag(77-85) observed variant
                {y}SLYNTVATL Gag(77-85) observed variant
                SLYNTVATL{l} Gag(77-85) observed variant
                {l}SLYNvVATL Gag(77-85) observed variant
                {c}SLYNlVATL Gag(77-85) observed variant
                {c}SLYNvVATL Gag(77-85) observed variant
                {g}SLYNTVATL Gag(77-85) observed variant
                {e}SLYNTVATL Gag(77-85) observed variant
                {l}gLYNTVATL Gag(77-85) observed variant
                SLYNTVAvL{l} Gag(77-85) observed variant
                {k}SvYNTVATL Gag(77-85) observed variant
                {v}gLYNTVATL Gag(77-85) observed variant
                SLYNTVATL{a} Gag(77-85) observed variant
                {v}SLYaTVATL Gag(77-85) observed variant
                SLYgTVATL{m} Gag(77-85) observed variant
                SLYNTVAvL{a} Gag(77-85) observed variant
                SLYgTVATL{a} Gag(77-85) observed variant
                SLYNvVATL{w} Gag(77-85) observed variant
                aLYNTVATL{l} Gag(77-85) observed variant
                SLYNTVAcL{l} Gag(77-85) observed variant
                SLYNTVATL{m} Gag(77-85) observed variant
                {a}SLYNTVAvL Gag(77-85) observed variant
                {v}SLYNTVAcL Gag(77-85) observed variant
                SLYcTVATL Gag(77-85) non-susceptible form
                SLYgTVATL Gag(77-85) observed variant
                SLYhTVATL Gag(77-85) observed variant
                SLYhlVATL Gag(77-85) observed variant
                SLYNmVATL Gag(77-85) observed variant
                SLYNTVvTL Gag(77-85) observed variant
                cLYNTVATL Gag(77-85) observed variant
                {v}SLYNTVATL{l} Gag(77-85) observed variant
                {c}aLYNTVATL Gag(77-85) observed variant
                {q}aLYNTVATL Gag(77-85) observed variant
                {a}SLYNTVATv Gag(77-85) observed variant
                SLYNTVAvL{m} Gag(77-85) observed variant
                {v}SvYNTVATL Gag(77-85) observed variant
                SLYgTVcTL Gag(77-85) observed variant
                SLYNTVATL{r} Gag(77-85) observed variant
                SLYNTVATL Gag(77-85) A*02:01 humanized mouse epitope
                SLYNTVATL Gag(77-85) A*02:01 transgenic mouse epitope
                SLYNTVATL Gag(77-85) A*02:01, A*02:14 human epitope
                SLYNTVATL Gag(77-85) A*02:02 human epitope
                SLYNTVATL Gag(77-85) A*02:02 human epitope
                SLYNTVATL Gag(77-85) A*02:02 human epitope
                SLYNTVATL Gag(77-85) A*02:02, A2 human epitope
                SLfNTVATL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) A*02:05 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTiATL Gag(77-85) susceptible form
                SLYNTiAvL Gag(77-85) susceptible form
                SLYNTVAvL Gag(77-85) susceptible form
                SLfNTVATL Gag(77-85) susceptible form
                SLfNTiAvL Gag(77-85) susceptible form
                SLfNTVAvL Gag(77-85) susceptible form
                SLfNTiATL Gag(77-85) susceptible form
                SLYNsVATL Gag(77-85) susceptible form
                SLYqTVATL Gag(77-85) susceptible form
                SLYlTVATL Gag(77-85) susceptible form
                aLYNTVATL Gag(77-85) susceptible form
                SLaNTVATL Gag(77-85) non-susceptible form
                SLYaTVATL Gag(77-85) non-susceptible form
                SLYNTaATL Gag(77-85) diminished response
                SLYNTVAaL Gag(77-85) diminished response
                aLYNTaAaL Gag(77-85) non-susceptible form
                SLYNvVATL Gag(77-85) non-susceptible form
                SLYNlVAvL Gag(77-85) escape documented in this paper; TCR related mutation
                SLYNlVAvL Gag(77-85) escape documented in this paper; TCR related mutation
                SLYNaVATL Gag(77-85) escape documented in this paper; TCR related mutation
                SLYNaiATL Gag(77-85) escape documented in this paper; TCR related mutation
                SLYNlVAvL Gag(77-85) escape documented in this paper; TCR related mutation
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 transgenic mouse epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLfNTVATL Gag(77-85) observed variant
                SLfNTVAvL Gag(77-85) diminished HLA binding or increased off-rate
                SLsNTVATL Gag(77-85) diminished HLA binding or increased off-rate
                SsfNTVATL Gag(77-85) observed variant
                SLlNTVATL Gag(77-85) diminished HLA binding or increased off-rate
                SLcNTVATL Gag(77-85) diminished HLA binding or increased off-rate
                SLYNTiATL Gag(77-85) observed variant
                SLfNaVATL Gag(77-85) diminished HLA binding or increased off-rate
                SLfNTiAvL Gag(77-85) diminished HLA binding or increased off-rate
                SLfNTiATL Gag(77-85) observed variant
                SLYNTiAvL Gag(77-85) diminished HLA binding or increased off-rate
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTiATL Gag(77-85) non-susceptible form; susceptible form
                SLYNTVAvL Gag(77-85) observed variant
                SLfNTVAvL Gag(77-85) escape documented in this paper
                SLfNTVATL Gag(77-85) diminished HLA binding or increased off-rate; susceptible form
                SLfNTiATL Gag(77-85) diminished response
                SLfNTiAvL Gag(77-85) escape documented in this paper; TCR related mutation
                SLhNaVAvL Gag(77-85) susceptible form
                SLYNTiAvL Gag(77-85) diminished response
                SLYNTiAiL Gag(77-85) observed variant
                SLfNTVATv Gag(77-85) susceptible form
                SLYNaVATL Gag(77-85) susceptible form
                SLYNlVAvL Gag(77-85) diminished HLA binding or increased off-rate
                SLYNTVAif Gag(77-85) diminished HLA binding or increased off-rate
                SLfNaVATL Gag(77-85) reversion; susceptible form
                SLfNaVAvL Gag(77-85) susceptible form
                SLfNmVATL Gag(77-85) susceptible form
                SLYNTVsTL Gag(77-85) susceptible form
                SLYNTitvL Gag(77-85) susceptible form
                SLYNTisvL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) A2 human, mouse epitope
                SLYNTVAaL Gag(77-85) susceptible form
                lLYNTVATL Gag(77-85) susceptible form
                SLYNTVAsL Gag(77-85) susceptible form
                SLYNTpATL Gag(77-85) susceptible form
                lLYNTVAaL Gag(77-85) susceptible form
                lLYNTVAsL Gag(77-85) susceptible form
                lLYNTVlTL Gag(77-85) susceptible form
                SLYNTsAaL Gag(77-85) susceptible form
                lLYNTpATL Gag(77-85) susceptible form
                SLYNTpAaL Gag(77-85) susceptible form
                SLYNTpAsL Gag(77-85) susceptible form
                SLhNwslaL Gag(77-85) susceptible form
                SLwNwplaL Gag(77-85) susceptible form
                SLwNwplsL Gag(77-85) susceptible form
                SLhNwplaL Gag(77-85) susceptible form
                SLhNwplsL Gag(77-85) susceptible form
                lLwNTslaL Gag(77-85) susceptible form
                lLwNwslaL Gag(77-85) susceptible form
                lLwNwslsL Gag(77-85) susceptible form
                lLwNwplaL Gag(77-85) susceptible form
                lLhNwslaL Gag(77-85) susceptible form
                lLhNwplsL Gag(77-85) susceptible form
                SLfNTVATL Gag(77-85) escape documented in this paper; susceptible form
                SLfNTVAvL Gag(77-85) diminished response; escape documented in this paper
                SLfNTiAvL Gag(77-85) escape documented in this paper; susceptible form
                SLYNTiATL Gag(77-85) diminished response; susceptible form
                SLYNTiAvL Gag(77-85) diminished response; susceptible form
                SvYNTVATL Gag(77-85) diminished response; susceptible form
                SLYNTVAvL Gag(77-85) diminished response; susceptible form
                SLYNTVATL Gag(77-85) A2 human epitope
                SLfNTVATL Gag(77-85) observed variant
                SLFNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLfNTiATL Gag(77-85) escape documented in this paper
                SLfNTiAaL Gag(77-85) observed variant
                SLfNTVAvL Gag(77-85) escape documented in this paper
                SLfsTVAvL Gag(77-85) observed variant
                SLfNTVAvp Gag(77-85) observed variant
                SLfNTiAvL Gag(77-85) observed variant
                SLYNTVATL Gag(77-85) A2 human epitope
                SLfNTVATL Gag(77-85) observed variant
                SLYNTiATL Gag(77-85) observed variant
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 transgenic mouse epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 transgenic mouse epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVAvL Gag(77-85) susceptible form
                SLfNTVAvL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human, transgenic mouse epitope
                SLfNTVATL Gag(77-85) susceptible form
                SLYNlVATL Gag(77-85) susceptible form
                SLfNlVATL Gag(77-85) susceptible form
                SiYNlVATL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) A2 human epitope
                SLFNTVATL Gag(77-85) A2 human epitope
                SLyNTVATL Gag(77-85) escape documented in this paper
                SLyNaVATL Gag(77-85) escape documented in this paper
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLfNTVcvi Gag(77-85) diminished response; escape documented in this paper; subtype-specific non-susceptible form; TCR related mutation
                SLfNTVATL Gag(77-85) diminished response; escape documented in this paper; subtype-specific non-susceptible form; TCR related mutation
                SLfNaVATL Gag(77-85) diminished response; escape documented in this paper; subtype-specific non-susceptible form; TCR related mutation
                SLaNTVATL Gag(77-85) diminished response; escape documented in this paper; TCR related mutation
                SLYaTVATL Gag(77-85) diminished response; escape documented in this paper; TCR related mutation
                SLYNaVATL Gag(77-85) diminished response; escape documented in this paper; TCR related mutation
                SLYNTaATL Gag(77-85) susceptible form
                SLYNTVAaL Gag(77-85) diminished response; escape documented in this paper; TCR related mutation
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLfNTVATL Gag(77-85) escape documented in this paper; susceptible form; TCR related mutation
                SLYNTiATL Gag(77-85) escape documented in this paper
                SLYNTiAvL Gag(77-85) escape documented in this paper; non-susceptible form; susceptible form; TCR related mutation
                SLfNTiATL Gag(77-85) escape documented in this paper; non-susceptible form; susceptible form; TCR related mutation
                SLYNlVAvL Gag(77-85) escape documented in this paper; non-susceptible form; TCR related mutation
                SLYNTVAaL Gag(77-85) observed variant
                SLYNTVATL Gag(77-85) A2 epitope
                SLYNTAVTL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human, transgenic mouse epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 mouse epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLfNTVATL Gag(77-85) escape documented in this paper
                SLYNTVAvL Gag(77-85) escape documented in this paper
                SLYNTIATL Gag(77-85) A2 human epitope
                SLFNTVATL Gag(77-85) A2 human epitope
                SLyNTVATL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLfNTVATL Gag(77-85) susceptible form
                SLYNTiATL Gag(77-85) susceptible form
                SLYNTVAvL Gag(77-85) susceptible form
                SLYNaVATL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLfNTVATL Gag(77-85) subtype-specific susceptible form
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVAvL Gag(77-85) diminished response
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLfNTVATL Gag(77-85) observed variant
                SLYNTVAvL Gag(77-85) observed variant
                SLYNTVATi Gag(77-85) observed variant
                SLfNTVATi Gag(77-85) observed variant
                SLnNaiAvL Gag(77-85) observed variant
                SvYNTVATL Gag(77-85) observed variant
                SLFNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVAVL Gag(77-85) A2 human epitope
                SLFNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 human epitope
                SLYNTVATL Gag(77-85) A2 humanized mouse epitope
                SLYNTVATL Gag(77-85) A2 epitope
                SLYNTVATL Gag(77-85) A2, A68 human epitope
                SLfNTiATL Gag(77-85) diminished response
                SLYNTVATL Gag(77-85) B*57 human epitope
                SLYNTVATL Gag(77-85) C*14 human epitope
                SLYNTVATL Gag(77-85) H-2d human, mouse epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLFNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                pLYNTVATL Gag(77-85) HLA association; TCR related mutation
                SLfNTVATL Gag(77-85) HLA association; TCR related mutation
                SLYNTiATL Gag(77-85) HLA association; TCR related mutation
                SLfNTVAvL Gag(77-85) HLA association; TCR related mutation
                SLfNaVAvL Gag(77-85) HLA association; TCR related mutation
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) epitope
                SLYNTVAvL Gag(77-85) susceptible form
                SLYNTiATL Gag(77-85) escape documented in this paper; susceptible form
                SLYNTiAvL Gag(77-85) susceptible form
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATL Gag(77-85) human epitope
                SLYNTVATLY Gag(77-86) A*02 human epitope
                SLYNTVAvLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                SLYNTiATLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                SLYNTiAvLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                SLfNTVATLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                SLfNTiAvLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                SLfNTVAvLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                SLfNTiATLY Gag(77-86) diminished HLA binding or increased off-rate; escape documented in this paper; susceptible form
                SLYNTVATLY Gag(77-86) A*02 human epitope
                SLYNTVATLY Gag(77-86) A*02:01 human epitope
                SLYNTVATLY Gag(77-86) A2 human epitope
                SLYNTVATLY Gag(77-86) A2 human epitope
                SLFNTVATLY Gag(77-86) human epitope
                SLYNTVATLY Gag(77-86) human epitope
                SLYNTVATLY Gag(77-86) human epitope
                SLYNIVATLWCVH Gag(77-89) human epitope
                SLYNTVATLYCVHQR Gag(77-91) A*02:01, A*30:02 human epitope
                SLfNTVATLYCVHQR Gag(77-91) susceptible form
                SLYNTVATLYCVHQR Gag(77-91) A2, B44, B60 human epitope
                SLYNTVATLYCVHQR Gag(77-91) H-2d transgenic mouse epitope
                SLYNTVATLYCVHQR Gag(77-91) mouse epitope
                SLYNTVATLYCVHQR Gag(77-91) human epitope
                SLYNTVATLYCVHQRIEV Gag(77-94) human epitope
                SLYNTVATLYCVHQRIEV Gag(77-94) human epitope
                 LYNTVATL Gag(78-85) A*02 human epitope
                 LYNTVATL Gag(78-85) A24 human epitope
                 LYNTVATL Gag(78-85) C*14 human epitope
                 LYNTVAVL Gag(78-85) C*14 human epitope
                 LYNTVATL Gag(78-85) C*14 human epitope
                 LYNTVATL Gag(78-85) C*14 human epitope
                 LYNTVATL Gag(78-85) C*14 human epitope
                 LYNTVATL Gag(78-85) C*14:02 human epitope
                 LYNTVATL Gag(78-85) C*14:02, C*14:03 human epitope
                 LYNTVATL Gag(78-85) H-2d mouse epitope
                 LYNTVATL Gag(78-85) human epitope
                 LYNTVATLY Gag(78-86) A*02 human epitope
                 LYNTVATLY Gag(78-86) A*29 human epitope
                 LYNTVATLY Gag(78-86) A*29 human epitope
                 LYNTVATLY Gag(78-86) A*29 human epitope
                 LYNTVAVLY Gag(78-86) A*29 human epitope
                 LYNTiAVLY Gag(78-86) observed variant
                 LfNTiAVLY Gag(78-86) observed variant
                 LfNTVAVLY Gag(78-86) observed variant
                 LYNTVATLY Gag(78-86) A*29, B*44 epitope
                 LYNTVATLY Gag(78-86) A29 human epitope
                 LFNTVATLY Gag(78-86) A*29:02 human epitope
                 LYNTVATLY Gag(78-86) A*29:02 human epitope
                 LYNTVATLY Gag(78-86) A*29:02 human epitope
                 LYNTIATLY Gag(78-86) A*29:02 human epitope
                 LYNTVATLY Gag(78-86) A*29:02, B*44:03 human epitope
                 LYNTVATLY Gag(78-86) A*29:02, B*44:03 human epitope
                 LYNTVATLY Gag(78-86) A*30 human epitope
                 LYNTVATLY Gag(78-86) B*44:03 human epitope
                 LYNTVATLY Gag(78-86) B*81 human epitope
                 LYNTVATLY Gag(78-86) C*14 human epitope
                 LYNTVATLY Gag(78-86) human epitope
                 LFNTVATLY Gag(78-86) human epitope
                 LyNTVATLY Gag(78-86) observed variant
                 LYNTVATLY Gag(78-86) human epitope
                 LYNTVATLY Gag(78-86) human epitope
                 LFNTVATLYCV Gag(78-88) A*02 human epitope
                 LYNTVATLYCVHQRI Gag(78-92) human epitope
                  YNIVATLWCVHQ Gag(79-90) human epitope
                  YNtVATLWCVHQ Gag(79-90) subtype-specific susceptible form
                  YNTVATLYCVHQRI Gag(79-92) human epitope
                   NTVATLYCV Gag(80-88) A2 human, transgenic mouse epitope
                   NTVATLYCV Gag(80-88) A2 human epitope
                   NTVATLYCV Gag(80-88) A2 human epitope
                   NaiAvLYCV Gag(80-88) observed variant
                   NTVAvLYCV Gag(80-88) observed variant
                   NTVATiYCV Gag(80-88) observed variant
                   NTVATLYCV Gag(80-88) observed variant
                    TVATLYCVH Gag(81-89) C*12:02 human epitope
                    TVATLYCVH Gag(81-89) human epitope
                    TVATLYCVHQRIEVK Gag(81-95) mouse epitope
                    TVATLYCVHQRIEVKDTKEA Gag(81-100) human epitope
                     VATLYCVHQ Gag(82-90) human epitope
                     IATLWCVHQR Gag(82-91) A*11 human epitope
                     IAVLYCVHQR Gag(82-91) A*11 epitope
                     IvVLYCVHQR Gag(82-91) observed variant
                     IATLWCVHQR Gag(82-91) A11 human epitope
                     IATLWCVHQR Gag(82-91) human epitope
                     VATLYCVHQRI Gag(82-92) A*11 human epitope
                     VvTLYCVHQRI Gag(82-92) susceptible form
                     VATLYCVHQRIEVK Gag(82-95) human epitope
Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health